Can I drink alcohol with Taltz?

Medically reviewed by Carmen Pope, BPharm. Last updated on Jan 20, 2025.

Official Answer by Drugs.com

Alcohol is not known to interact with Taltz (ixekizumab), a humanized interleukin-17A antagonist used to treat adults and children with moderate-to-severe plaque psoriasis, as well as adults with active psoriatic arthritis, ankylosing spondylitis and non-radiographic axial spondyloarthritis with objective signs of inflammation.

Analysis of short- and long-term safety data from seven clinical trials of Taltz, which involved 4209 patients with psoriasis, concluded that Taltz has an acceptable safety profile and did not uncover any unexpected safety findings. No interaction between alcohol and Taltz was reported in the analysis.

Dermatologists advise patients with psoriasis to limit alcohol

While Taltz may not interact with alcohol, the American Academy of Dermatology (AAD) and the National Psoriasis Foundation (NPF) put out guidelines in April 2019 recommending that dermatologists should strongly advise patients with psoriasis to limit alcohol intake. It is thought that consumption of alcohol increases the risk for severe disease in patients with psoriasis. Not only is limiting alcohol recommended in patients with psoriasis to improve skin disease, but it is also recommended to improve overall health.

Studies have revealed links between alcohol consumption and psoriasis, including that people with psoriasis tend to drink more than people who don’t suffer from the condition. People with psoriasis also have about a 60% greater risk of dying from alcohol-related causes compared with similar people who do not have psoriasis.

References

British Association of Dermatologists (BAD). Ixekizumab. [Accessed April 28, 2020]. Available online at: https://www.bad.org.uk/shared/get-file.ashx?id=6314&itemtype=document
Strober B, Leonardi C, Papp KA, et al. Short- and long-term safety outcomes with ixekizumab from 7 clinical trials in psoriasis: Etanercept comparisons and integrated data. J Am Acad Dermatol. 2017 Mar;76(3):432-440.e17. doi: 10.1016/j.jaad.2016.09.026.
Parisi R, Webb RT, Carr MJ, et al. Alcohol-Related Mortality in Patients With Psoriasis: A Population-Based Cohort Study. JAMA Dermatol. 2017 Dec 1;153(12):1256-1262. doi: 10.1001/jamadermatol.2017.3225.
Food and Drug Administration (FDA). Highlights of Prescribing Information. Taltz. [Accessed June 11, 2020]. Available online at: https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/125521s019lbl.pdf.

How long before Taltz works?

Treatment with Taltz (ixekizumab) starts to improve symptoms in patients with moderate-to-severe psoriasis within about 1-2 weeks, according to clinical trial results. After 12 weeks, nearly 90% of patients will have significantly clearer skin. Continue reading

Is weight gain a side effect of Taltz?

Weight gain is not a known side effect of Taltz (ixekizumab), a humanized interleukin-17A antagonist used to treat adults and children with moderate-to-severe plaque psoriasis, as well as other conditions.

While body weight can impact how well some drug treatments work, researchers have found that treatment with Taltz is safe and effective regardless of a patient's body weight. Continue reading

What are Monoclonal Antibodies and how do they work?

Monoclonal antibodies (mAbs) are man-made proteins that mimic the natural antibodies produced by our immune systems. Monoclonal antibodies can be formulated into medicines to treat various types of illnesses, such as cancer, rheumatoid arthritis or psoriasis.

Can I drink alcohol with Taltz?

Dermatologists advise patients with psoriasis to limit alcohol

Read next

How long before Taltz works?

Is weight gain a side effect of Taltz?

What are Monoclonal Antibodies and how do they work?

See also:

Aimovig

Botox

Stelara

Nurtec ODT

Depakote

Topamax

Emgality

Timolol

Valproic acid

Divalproex sodium

Related medical questions

Drug information

Related support groups